Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease - Wikidata - awgldk - TriplyDB

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease

http://www.wikidata.org/entity/Q28067464

about

The Burden and Long-term Respiratory Morbidity Associated with Respiratory Syncytial Virus Infection in Early Childhood.Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease.Defining the Incidence and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Children with Chronic Diseases.National cohort study showed that infants with Down's syndrome faced a high risk of hospitalisation for the respiratory syncytial virus.Past, Present and Future Approaches to the Prevention and Treatment of Respiratory Syncytial Virus Infection in Children.Molecular Requirements for Self-Interaction of the Respiratory Syncytial Virus Matrix Protein in Living Mammalian Cells.Respiratory syncytial virus hospitalization and incurred morbidities the season after prophylaxis Seasonality and clinical impact of human parainfluenza viruses

P2860

Q33732535-316A1C5F-A6E8-4910-B5AA-C086FD8B8670 Q36245207-343D97EC-19E0-4F8F-89B8-06F1882D49B3 Q38373552-7F971420-DDF2-4EB6-BA46-25E8543767B4 Q38757467-56B5696A-9C94-42E0-A5C0-7C9362E3821F Q50262223-6FEA84BB-5E81-4A0D-AC19-C0A96BBF85EC Q54261279-DA50D6EF-DD9A-4020-9269-15734D6C769C Q58084597-1DB542D5-2CA9-4867-AB72-A75B14B90379 Q58692316-617DB5B6-AC31-4A80-AAD0-EF88C1A4AEC5

P2860

Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Chronic Lung Disease

http://www.wikidata.org/entity/Q28067464

description

2016 nî lūn-bûn

@nan

2016 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@ast

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@en

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@nl

type

label

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@ast

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@en

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@nl

prefLabel

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@ast

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@en

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@nl

P1433

Q28067464-765C301C-E6A5-4FA1-8DBE-3E7878C6E6F1

P1476

Q28067464-44987F51-8C68-4371-AEE6-6044DB12479D

P2093

Q28067464-0F1572C4-4676-434F-8E81-9428A08F723E

Q28067464-31CFE69B-2CC5-49D7-BDD2-00F17E4830EA

Q28067464-459A543F-A5C3-4B1A-B932-4D12BFABEB6A

Q28067464-54D985EE-EE68-46A8-9E70-7198B7FAF05B

Q28067464-683F5F7D-FE73-4F0F-8B14-F6C200349A19

Q28067464-7F34E90D-FE6D-452B-9722-0F49C46EAB49

Q28067464-9B53FFFF-F48B-425C-AC44-AB7EED3940DE

P2860

Q28067464-00D8A879-31C3-45D1-B17E-B72E70D728C3

Q28067464-0301DBA1-DC0F-4FD5-9184-AA4986EAEE08

Q28067464-0398BE02-4DEE-4900-B180-241180734A27

Q28067464-05BA3F25-7AA7-49F4-8D10-EBCD7E487341

Q28067464-07E4D328-293D-4514-90C6-1483559CCF14

Q28067464-0D01CB30-227A-46AD-B43E-567E1E9179EF

Q28067464-0E1A2260-0EAC-41DB-B013-DC1644EAE930

Q28067464-15636C4E-23F3-4FE2-843F-4F62B525A622

Q28067464-1727153B-D118-4DFA-AD50-24287F2B6E84

Q28067464-189B3393-0B6E-43F8-B692-66A8C3C5A695

P2888

Q28067464-7A735366-4289-42D2-A27F-7A872C8115A4

P304

Q28067464-DAB46D44-E6EE-4CE1-984F-AAB2D4D9AF7D

P31

Q28067464-0EEFC3BC-AAC5-43E2-A2A3-B3D08E180035

P356

Q28067464-8B02AAE8-BE0C-4AED-BB4D-1BDA80968ADD

P407

Q28067464-3D60CD0F-9B22-45F7-833B-AC11F1F8BBE0

P433

Q28067464-73072D91-38B1-496E-A359-83ABAC48027B

P478

Q28067464-3D52B4B3-CD52-466C-BBB9-9ACDAD0021C0

P50

Q28067464-081c0dc5-4d0f-7bc7-e26f-3dee163bab28

P577

Q28067464-92DB6F1B-41B3-41AB-8C89-586D4A72BB38

P6179

Q28067464-9B760573-1E94-4258-A383-980999641B0C

P698

Q28067464-95C820E1-18E2-4FD5-A5A2-84EED72F875F

P921

Q28067464-2E3142F5-BBA0-464C-AFB4-F8374F441842

P932

Q28067464-EDBBF61A-CE9B-4EAB-BAE4-6CC16C27EB49

P356

S40121-016-0137-7

P1433

Infectious diseases and therapy

P1476

Defining the Risk and Associat ...... ants with Chronic Lung Disease

@en

P2093

Bosco Paes

http://www.w3.org/2001/XMLSchema#string

Brigitte Fauroux

http://www.w3.org/2001/XMLSchema#string

Eric A. F. Simões

http://www.w3.org/2001/XMLSchema#string

Louis Bont

http://www.w3.org/2001/XMLSchema#string

Paolo Manzoni

http://www.w3.org/2001/XMLSchema#string

Paul A. Checchia

http://www.w3.org/2001/XMLSchema#string

Xavier Carbonell-Estrany

http://www.w3.org/2001/XMLSchema#string

P2860

Defining the Epidemiology and Burden of Severe Respiratory Syncytial Virus Infection Among Infants and Children in Western Countries

Bronchopulmonary dysplasia

Updated guidance for palivizumab prophylaxis among infants and young children at increased risk of hospitalization for respiratory syncytial virus infection

Pulmonary disease following respirator therapy of hyaline-membrane disease. Bronchopulmonary dysplasia

Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Incidence and risk factors of hospitalization for bronchiolitis in preterm children: a retrospective longitudinal study in Italy

Chronic lung disease in the preterm infant. Lessons learned from animal models

Variable morbidity of respiratory syncytial virus infection in patients with underlying lung disease: a review of the PICNIC RSV database. Pediatric Investigators Collaborative Network on Infections in Canada.

A novel six consecutive monthly doses of palivizumab prophylaxis protocol for the prevention of respiratory syncytial virus infection in high-risk preterm infants in Taiwan.

P2888

s40121-016-0137-7

P304

453-471

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40121-016-0137-7

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Josep Figueras Aloy

P577

2016-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1019331586

http://www.w3.org/2001/XMLSchema#string

P698

27864751

http://www.w3.org/2001/XMLSchema#string

P921

child mortality

P932

5125140

http://www.w3.org/2001/XMLSchema#string